| Factor Information | |
|---|---|
| Data ID | 377 |
| Factor | fresh frozen plasma (FFP) exposure |
| Description | Thrombosis is a cause of considerable morbidity and mortality in children who undergo surgery for congenital heart disease (CHD). Data on how to prevent this complication are sorely needed. |
| Biomarker | NA |
| Classification | A12 (clinical factor - treatment) |
| Association | |
|---|---|
| Application | prognosis |
| Objective | identify risk factors for developing venous or arterial thrombosis following pediatric cardiac surgery |
| p Value | 0.002 |
| Conclusion | The occurrence of thrombosis after pediatric cardiac surgery at our institution was 6.2%, similar to what has been reported in other studies, despite frequent use of low molecular weight heparin. |
| Risk Factor | unknown |
| CHD Type | |
|---|---|
| ID | 444 |
| CHD Type | isolated CHD |
| CHD Subtype | HRHS/HLHS/other |
| Reference | |
|---|---|
| PMID | 30234677 |
| Year | 2018 |
| Title | Analysis of Patient Characteristics and Risk Factors for Thrombosis After Surgery for Congenital Heart Disease. |
| Sample | ||
|---|---|---|
| Population | children | |
| Source | A retrospective cohort study | |
| Region | Indiana,USA | |
| Method | reviewed | |
| Race | North America | |
| Disease History | N/A | |
| Treatment History | cardiothoracic surgery | |
| Group | thrombosis patients(Treatment) | no thrombosis patients(Control) |
| Number | 23 | 23 |
| Age | 0.7 months | 0.7 months |
| Gender (Male: Female) | 17:16 | 32:32 |
| Marker Level | 0.7 | 0.36 |
